Yi Yao
Impact in
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- Protein purification and stability
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 27
- Cancer Immunotherapy and Biomarkers 12
-
- Cancer-related molecular mechanisms research 5
- Co-authors
- Ching C. Wang (3 shared papers)Qibin Song (33 shared papers)Christopher P. Hill (2 shared papers)Frank G. Whitby (2 shared papers)Eugene I. Masters (2 shared papers)Michael D. Scholle (2 shared papers)Jeffery L. Cleland (2 shared papers)Chia‐Wei Wang (2 shared papers)
- Journals
- Frontiers in Oncology (8 papers)PLoS ONE (7 papers)Scientific Reports (4 papers)Thrombosis Research (3 papers)Toxics (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Yi Yao
172 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 132
- Molecular Biology 1.2k
- Oncology 347
- Cancer Research 201
- Immunology 238
- Pharmaceutical Science 83
Countries citing papers authored by Yi Yao
This map shows the geographic impact of Yi Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Yao more than expected).
Fields of papers citing papers by Yi Yao
This network shows the impact of papers produced by Yi Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Yao. The network helps show where Yi Yao may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Yao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 182 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 413 | |
| 2 | 2009 | 388 | |
| 3 | 2014 | 167 | |
| 4 | 2017 | 149 | |
| 5 | 2019 | 88 | |
| 6 | 2006 | 78 | |
| 7 | 2019 | 78 | |
| 8 | 2021 | 74 | |
| 9 | 2010 | 66 | |
| 10 | 2021 | 65 | |
| 11 | 2002 | 60 | |
| 12 | 1999 | 52 | |
| 13 | 2010 | 48 | |
| 14 | 2009 | 46 | |
| 15 | 2023 | 44 | |
| 16 | 2018 | 43 | |
| 17 | 2020 | 42 | |
| 18 | 2018 | 41 | |
| 19 | 2021 | 40 | |
| 20 | 1999 | 39 |
About Yi Yao
Yi Yao is a scholar working on Oncology, Cancer Research, Molecular Biology, Nephrology and Hepatology, having authored 182 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Solid State Laser Technologies (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Ubiquitin and proteasome pathways (6 papers), Epilepsy research and treatment (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Ferroptosis and cancer prognosis (5 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Molecular Biology (1.2k citations), Oncology (347 citations), Cancer Research (201 citations), Immunology (238 citations) and Pharmaceutical Science (83 citations). Yi Yao has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Ching C. Wang, Qibin Song, Christopher P. Hill, Frank G. Whitby, Eugene I. Masters, Michael D. Scholle, Jeffery L. Cleland, Chia‐Wei Wang, J. Silverman and Willem P.C. Stemmer. Their work appears in journals such as Frontiers in Oncology, PLoS ONE, Scientific Reports, Thrombosis Research and Toxics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.